Inflammation occurs early during the Abeta deposition process in TgCRND8 mice
- PMID: 15212840
- DOI: 10.1016/j.neurobiolaging.2003.08.008
Inflammation occurs early during the Abeta deposition process in TgCRND8 mice
Abstract
Alzheimer's disease (AD) is characterized by a progressive cognitive decline leading to dementia and involves the deposition of amyloid-beta (Abeta) peptides into senile plaques. Other neuropathological features that accompany progression of the disease include a decrease in synaptic density, neurofibrillary tangles, dystrophic neurites, inflammation, and neuronal cell loss. In this study, we report the early kinetics of brain amyloid deposition and its associated inflammation in an early onset transgenic mouse model of AD (TgCRND8) harboring the human amyloid precursor protein gene with the Indiana and Swedish mutations. Both diffuse and compact plaques were detected as early as 9-10 weeks of age. Abeta-immunoreactive (Abeta-IR) plaques (4G8-positive) appeared first in the neocortex and amygdala, then in the hippocampal formation, and lastly in the thalamus. Compact plaques (ThioS-positive) with an amyloid core were observed as early as diffuse plaques were detected, but in lower numbers. Amyloid deposition increased progressively with age. The formation of plaques was concurrent with the appearance of activated microglial cells and shortly followed by the clustering of activated astrocytes around plaques at 13-14 weeks of age. This TgCRND8 mouse model allows for a rapid, time-dependent study of the relationship between the fibrillogenic process and the inflammatory response during the brain amyloidogenic process.
Similar articles
-
Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice.Eur J Neurosci. 2006 Oct;24(7):1923-34. doi: 10.1111/j.1460-9568.2006.05069.x. Eur J Neurosci. 2006. PMID: 17067295
-
Metallothionein-I and -III expression in animal models of Alzheimer disease.Neuroscience. 2006 Dec 28;143(4):911-22. doi: 10.1016/j.neuroscience.2006.08.054. Epub 2006 Oct 4. Neuroscience. 2006. PMID: 17027170
-
Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.Neurobiol Dis. 2006 Sep;23(3):653-62. doi: 10.1016/j.nbd.2006.05.010. Epub 2006 Jul 10. Neurobiol Dis. 2006. PMID: 16829076
-
[The lesions of Alzheimer's disease: which therapeutic perspectives?].Bull Acad Natl Med. 2008 Feb;192(2):303-18; discussion 318-21. Bull Acad Natl Med. 2008. PMID: 18819685 Review. French.
-
Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.Neuroscientist. 2007 Feb;13(1):38-48. doi: 10.1177/1073858406295610. Neuroscientist. 2007. PMID: 17229974 Review.
Cited by
-
Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice.Am J Pathol. 2006 Jan;168(1):245-60. doi: 10.2353/ajpath.2006.050752. Am J Pathol. 2006. PMID: 16400027 Free PMC article.
-
Mouse Models of Alzheimer's Disease.Front Mol Neurosci. 2022 Jun 21;15:912995. doi: 10.3389/fnmol.2022.912995. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35799899 Free PMC article. Review.
-
Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.FASEB J. 2009 Aug;23(8):2459-66. doi: 10.1096/fj.09-132928. Epub 2009 Apr 3. FASEB J. 2009. PMID: 19346295 Free PMC article.
-
The Complexity of Microglial Interactions With Innate and Adaptive Immune Cells in Alzheimer's Disease.Front Aging Neurosci. 2020 Nov 19;12:592359. doi: 10.3389/fnagi.2020.592359. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33328972 Free PMC article. Review.
-
Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.Mol Neurodegener. 2014 Oct 13;9:41. doi: 10.1186/1750-1326-9-41. Mol Neurodegener. 2014. PMID: 25312309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases